Abstract LB369: Final results of a phase I trial of evorpacept (ALX148), lenalidomide, and rituximab for patients with B-cell non-Hodgkin lymphoma
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Tony Z. Zhuang, Lei Feng, Andrey Tyshevich, Darya Shavronskaya, Julia Alesse, Noel English, Lizzie Sheehan, Nikita Syzrantsev, Alexander Nesmelov, Dai Chihara, Jason Westin, Sairah Ahmed, Luis Fayad, Jared Henderson, Kylie Dent, Elizabeth McChesney, Sattva Neelapu, Christopher R. Flowers, Paolo Strati
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409820643